BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seo S, Shin J, Lee W, Rhee YK, Cho C, Hong H, Lee K. Anti-colitis effect of Lactobacillus sakei K040706 via suppression of inflammatory responses in the dextran sulfate sodium-induced colitis mice model. Journal of Functional Foods 2017;29:256-68. [DOI: 10.1016/j.jff.2016.12.045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Mijan MA, Lim BO. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends. World J Gastroenterol 2018; 24(25): 2673-2685 [PMID: 29991873 DOI: 10.3748/wjg.v24.i25.2673] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 38] [Article Influence: 11.5] [Reference Citation Analysis]
2 Zhang S, Wang P, Zhang J, Wang W, Yao L, Gu C, Efferth T, Fu Y. 2′O-galloylhyperin attenuates LPS-induced acute lung injury via up-regulation antioxidation and inhibition of inflammatory responses in vivo. Chemico-Biological Interactions 2019;304:20-7. [DOI: 10.1016/j.cbi.2019.02.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Zhou HB, Chen J, Li S, Zhang J, Zhu CE, Ran H, Luo M, Pan X, Hu H, Wu C. Preparation of Acid-Resistant Microcapsules with Shell-Matrix Structure to Enhance Stability of Streptococcus Thermophilus IFFI 6038. J Food Sci 2017;82:1978-84. [PMID: 28696506 DOI: 10.1111/1750-3841.13774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Wang G, Liu Y, Lu Z, Yang Y, Xia Y, Lai PF, Ai L. The ameliorative effect of a Lactobacillus strain with good adhesion ability against dextran sulfate sodium-induced murine colitis. Food Funct 2019;10:397-409. [DOI: 10.1039/c8fo01453a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
5 Wang Y, Dilidaxi D, Wu Y, Sailike J, Sun X, Nabi XH. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomed Pharmacother 2020;125:109914. [PMID: 32035395 DOI: 10.1016/j.biopha.2020.109914] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
6 Kim KH, Chun BH, Baek JH, Roh SW, Lee SH, Jeon CO. Genomic and metabolic features of Lactobacillus sakei as revealed by its pan-genome and the metatranscriptome of kimchi fermentation. Food Microbiol 2020;86:103341. [PMID: 31703875 DOI: 10.1016/j.fm.2019.103341] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
7 Shibayama J, Kuda T, Shikano A, Fukunaga M, Takahashi H, Kimura B, Ishizaki S. Effects of rice bran and fermented rice bran suspensions on caecal microbiota in dextran sodium sulphate-induced inflammatory bowel disease model mice. Food Bioscience 2018;25:8-14. [DOI: 10.1016/j.fbio.2018.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
8 Xia Y, Chen Y, Wang G, Yang Y, Song X, Xiong Z, Zhang H, Lai P, Wang S, Ai L. Lactobacillus plantarum AR113 alleviates DSS-induced colitis by regulating the TLR4/MyD88/NF-κB pathway and gut microbiota composition. Journal of Functional Foods 2020;67:103854. [DOI: 10.1016/j.jff.2020.103854] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Rodrigues R, Guerra G, Soares J, Santos K, Rolim F, Assis P, Araújo D, de Araújo Júnior RF, Garcia VB, de Araújo AA, Queiroga R. Lactobacillus rhamnosus EM1107 in goat milk matrix modulates intestinal inflammation involving NF-κB p65 and SOCs-1 in an acid-induced colitis model. Journal of Functional Foods 2018;50:78-92. [DOI: 10.1016/j.jff.2018.09.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
10 Wang Y, Liu J, Huang Z, Li Y, Liang Y, Luo C, Ni C, Xie J, Su Z, Chen J, Li C. Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response. Eur J Pharmacol 2021;896:173912. [PMID: 33508280 DOI: 10.1016/j.ejphar.2021.173912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shamoon M, Martin NM, O'Brien CL. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications. Pharmacol Res. 2019;148:104344. [PMID: 31400403 DOI: 10.1016/j.phrs.2019.104344] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
12 Yokota Y, Shikano A, Kuda T, Takei M, Takahashi H, Kimura B. Lactobacillus plantarum AN1 cells increase caecal L. reuteri in an ICR mouse model of dextran sodium sulphate-induced inflammatory bowel disease. Int Immunopharmacol. 2018;56:119-127. [PMID: 29414641 DOI: 10.1016/j.intimp.2018.01.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
13 Wang Y, Wu Y, Sailike J, Sun X, Abuduwaili N, Tuoliuhan H, Yusufu M, Nabi X. Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1/M2 phenotype macrophage in db/db mice. Pharmacological Research 2020;161:105150. [DOI: 10.1016/j.phrs.2020.105150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]